Fingerprint
Dive into the research topics of 'Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
O. Hamid, C. Robert, A. Daud, F. S. Hodi, W. J. Hwu, R. Kefford, J. D. Wolchok, P. Hersey, R. Joseph, J. S. Weber, R. Dronca, T. C. Mitchell, A. Patnaik, H. M. Zarour, A. M. Joshua, Q. Zhao, E. Jensen, S. Ahsan, N. Ibrahim, A. Ribas
Research output: Contribution to journal › Article › peer-review
196
Scopus
citations